# Role of the MET Oncogene in Human Colorectal Cancer - A Translational Study

> **NCT02238821** · — · COMPLETED · sponsor: **Fondazione del Piemonte per l'Oncologia** · enrollment: 60 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02238821
- **Lead sponsor:** Fondazione del Piemonte per l'Oncologia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2016-09
- **Final completion:** 2016-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02238821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02238821, "Role of the MET Oncogene in Human Colorectal Cancer - A Translational Study". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02238821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*